Exact Mass: 604.2128961999999
Exact Mass Matches: 604.2128961999999
Found 154 metabolites which its exact mass value is equals to given mass value 604.2128961999999
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ferrocytochrome
C33H32FeN4O4 (604.1772821999999)
Ferricytochrome is a cytochrome containing reduced (ferrous) iron. Cytochrome c is an electron-carrying protein found in mitochondria of all aerobic organisms. It is part of the terminal oxidation chain, which completes the breakdown of foods to COZ and HzO, storing the liberated chemical energy in molecules of ATP. Like myoglobin, it is an iron porphyrin protein, made up of one heme group and one polypeptide chain. The iron atomalternates between the +2 and +3 oxidation state as the molecule interacts in turn with cytochrome reductase and cytochrome oxidase, each a large multimolecular complex (l-3). One of the goals of the present x-ray analysis is to understand how electron. transfer occurs into and out of cytochrome c, which will ultimately require a knowledge of the molecular structure in both the ferric and ferrous states. Ferricytochrome is a cytochrome containing reduced (ferrous) iron.
6-Hydroxysandoricin
6-Hydroxysandoricin is a constituent of Sandoricum koetjape (santol).
Modipafant
N-[4-[[3-[(1-Ethyl-3-fluoropiperidin-4-yl)amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-3-fluorophenyl]-2-(4-fluorophenyl)-3-oxopyridazine-4-carboxamide
[(1S,4aS,6S,7R,7aS)-6-acetyloxy-4-[[(2R,3R,4S,5S,6R)-3-acetyloxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-7-(acetyloxymethyl)-7-hydroxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-1-yl] 3-methylbutanoate
Daphnetoxin, 12-(benzoyloxy)-1,2-dihydro-, (12-beta)-
kadsuphilol U|rel-(5R,6R,7R,8S,14aR)-5-(acetyloxy)-5,6,7,8-tetrahydro-6-hydroxy-2,3-dimethoxy-6,7-dimethyl-1-oxo-1H,14H-10,12,13-trioxabenzo[1,8]cyclooct[1,2,3-cd]-as-indacen-8-yl (2E)-3-phenylprop-2-enoate
(1R,2S,4S,5S,6R,7R,9S,10S)-9-benzoyloxy-1,2,6,15-tetra-acetoxy-4-hydroxy-8-oxo-dihydro-beta-agarofuran
bis-5,6-dihydro-2(1H)-pyridonyl-trans-trans-trans-2-(2,4-dimethoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,3-cyclobutanedicarboxamide|piperarborenine D
kadsuphilol V|rel-(5R,6R,7R,8S,14aR)-5-(acetyloxy)-5,6,7,8-tetrahydro-6-hydroxy-1,2-dimethoxy-6,7-dimethyl-3-oxo-3H,14H-10,12,13-trioxabenzo[1,8]cyclooct[1,2,3-cd]-as-indacen-8-yl (2E)-3-phenylprop-2-enoate
6-Hydroxysandoricin
6?-O-p-hydroxybenzoyl-6-O-p-hydroxybenzoyl-5,7-bisdeoxycynanchoside
Dehydrobruceantinol
3-O-[(E)-3,4,5-trimethoxycinnamoyl]-beta-D-fructofuranosyl-(2->1)-(6-O-acetyl)-alpha-D-glucopyranoside|tricornose A
kaempferol 3-O-alpha-L-(4-O-acetyl)rhamnopyranoside-7-O-alpha-L-rhamnopyranoside|sutchuenoside A
1alpha,8alpha-oxido-3beta-acetoxy-2alpha-acelperoxy-1alpha,14alpha-dihydroxy-[3.3.110,2]-bicyclomeliac-7,19-olide
C31H40O12_Butanoic acid, 2-methyl-, 9-(3-furanyl)decahydro-2,6,8,9,14-pentahydroxy-3,8a-dimethyl-7-oxo-12H,13aH-3,6a,11b-[1,1,3]propanetriyl-2H,8H-oxireno[3,3a]indeno[5,4:4,5]pyrano[2,3-b]oxocin-4-yl ester
6-(furan-3-yl)-6,8,12,16,21-pentahydroxy-7,15-dimethyl-9-oxo-3,17,19-trioxaheptacyclo[9.9.3.0¹,¹⁰.0²,⁴.0²,⁷.0¹¹,¹⁸.0¹⁵,²³]tricosan-14-yl 2-methylbutanoate
[(1S,4aS,6S,7R,7aS)-6-acetyloxy-4-[[(2R,3R,4S,5S,6R)-3-acetyloxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-7-(acetyloxymethyl)-7-hydroxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-1-yl] 3-methylbutanoate_major
6-(furan-3-yl)-6,8,12,16,21-pentahydroxy-7,15-dimethyl-9-oxo-3,17,19-trioxaheptacyclo[9.9.3.0¹,¹⁰.0²,⁴.0²,⁷.0¹¹,¹⁸.0¹⁵,²³]tricosan-14-yl 2-methylbutanoate_major
Asp Glu Arg Trp
Asp Glu Trp Arg
Asp Arg Glu Trp
Asp Arg Trp Glu
Asp Trp Glu Arg
Asp Trp Arg Glu
Glu Asp Arg Trp
Glu Asp Trp Arg
Glu Phe Phe Tyr
Glu Phe Tyr Phe
Glu Met Tyr Tyr
Glu Arg Asp Trp
Glu Arg Trp Asp
Glu Trp Asp Arg
Glu Trp Arg Asp
Glu Tyr Phe Phe
Glu Tyr Met Tyr
Glu Tyr Tyr Met
Phe Glu Phe Tyr
Phe Glu Tyr Phe
Phe Phe Glu Tyr
Phe Phe Tyr Glu
Phe Tyr Glu Phe
Phe Tyr Phe Glu
Met Glu Tyr Tyr
Met Tyr Glu Tyr
Met Tyr Tyr Glu
Pro Tyr Tyr Tyr
Arg Asp Glu Trp
Arg Asp Trp Glu
Arg Glu Asp Trp
Arg Glu Trp Asp
Arg Trp Asp Glu
Arg Trp Glu Asp
Trp Asp Glu Arg
Trp Asp Arg Glu
Trp Glu Asp Arg
Trp Glu Arg Asp
Trp Arg Asp Glu
Trp Arg Glu Asp
Tyr Glu Phe Phe
Tyr Glu Met Tyr
Tyr Glu Tyr Met
Tyr Phe Glu Phe
Tyr Phe Phe Glu
Tyr Met Glu Tyr
Tyr Met Tyr Glu
Tyr Pro Tyr Tyr
Tyr Tyr Glu Met
Tyr Tyr Met Glu
Tyr Tyr Pro Tyr
Tyr Tyr Tyr Pro
Hp 5B
1-Benzoyl-4-[4-(1,1-dimethylpropyl)phenoxy]-6-(phenylamino)-3H-dibenz[f,ij]isoquinoline-2,7-dione
Oxantel pamoate
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
(-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooctadiene)rhodium(I) tetrafluoroborate
N,N-BIS[O-(DIPHENYLPHOSPHINO)BENZYLIDENE]ETHYLENEDIAMINE
Quarfloxin
C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
O-Allyl-N-(9-anthracenylmethyl)cinchonidinium bromide
(1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyltriacetate
O-methyl-4-O-[alpha-L-fucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->3)-2-O-methyl-alpha-L-rhamnopyranosyl]-hydroxybenzoate
3-[(21S,22S)-11,16-bis(ethenyl)-12-formyl-4-hydroxy-3-methoxycarbonyl-17,21,26-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
alpha-D-GlcpA4Me-(1->2)-beta-D-Xylp-(1->4)-beta-D-Xylp-(1->4)-beta-D-Xylp
[(3S,4S)-10-hydroxy-5-[(3S)-10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-4-yl] acetate
N-[[(4R,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4R,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5S)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[(5S,6R,9R)-8-(3-chlorophenyl)sulfonyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
C28H33ClN4O7S (604.1758378000001)
N-[[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
N-[[(4S,5R)-8-(3-cyclopentylprop-1-ynyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-2-methoxy-N-methylbenzenesulfonamide
C30H40N2O7S2 (604.2276810000001)
1-(2-fluorophenyl)-3-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2,2,2-trifluoroethylsulfonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
(2S,3S,4R,5R,6S)-4,5-dihydroxy-6-[(2S,3R,4S,5R)-4-hydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(3R,4R,5R,6R)-4,5,6-trihydroxyoxan-3-yl]oxyoxan-3-yl]oxy-3-methoxyoxane-2-carboxylic acid
IPN60090 (dihydrochloride)
IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1?(GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers[1][2].
6-(hydroxymethyl)-1,6-dimethyl-7h,8h,9h-phenanthro[1,2-b]furan-10,11-dione; tanshinone iia
(3s,4s)-2-[(2s)-1-amino-6-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}hexan-2-yl]-3,7,8-trihydroxy-4-(1h-indol-3-yl)-1-oxo-4h-isoquinoline-3-carboxylic acid
[(1s,3r,4s,5s,7r,9r,10s,11s,12r)-10-(furan-3-yl)-11-hydroxy-8-[(2-hydroxy-3-methylbutanoyl)oxy]-4-[(2r,3r)-2-(hydroxymethyl)-2-methyl-5-oxooxolan-3-yl]-4,9-dimethyl-2-methylidene-6,13-dioxatetracyclo[7.4.0.0¹,¹².0³,⁷]tridecan-5-yl]acetic acid
(2s,3s,4r,5r,6s)-6-{[(2s,3r,4s,5r)-2-{[(3r,4r,5r,6s)-4,5-dihydroxy-6-{[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxyoxan-3-yl]oxy}-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid
methyl (2s)-2-[(1r,2s,5s,6s,10s,11r,12s,13s,14s,15s,17r,18r)-12,14-bis(acetyloxy)-6-(furan-3-yl)-11,17-dihydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]-2-hydroxyacetate
2-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-4-hydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate
1-[(8r,21r)-13-hydroxy-16,27-dimethoxy-22-methyl-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25,27,32-dodecaen-7-yl]ethanone
C37H36N2O6 (604.2573236000001)
2-[(5-carbamimidamido-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1-hydroxypentylidene)amino]-5-[n-(2,3-dihydroxybenzoyloxy)formamido]pentanoic acid
C26H32N6O11 (604.2128961999999)